Zhengjie Zhou

Zhengjie Zhou is an Assistant Professor in the Center for Inflammation and Lung Research (CILR) at the Lewis Katz School of Medicine, Temple University. His work bridges nanomedicine, vascular biology, and pulmonary research to develop cell-targeted therapies for inflammatory lung diseases.

• Education: PhD in Biochemistry and Molecular Biology from East China Normal University (2013–2018), BS in Pharmacy and Organic Chemistry from Lanzhou University (2009–2013).

Research Interests: The Zhou Lab focuses on precise modulation of cell-specific signaling pathways in inflammation and disease. Key areas include:

• Lung Biology in Inflammation and Injury
• Nanomedicine and mRNA-loaded Lipid Nanoparticles
• Endothelial Mechanosensitivity in Vascular Inflammation

Scientific Trends: Recent work emphasizes mRNA delivery systems for vascular and lung diseases (2025), targeted nanocarriers for fibrosis (2025), and polyelectrolyte micelles for vascular complications (2021). Earlier studies explore photothermal cancer therapies (2016–2020) and autophagy modulation (2016–2017).

Scientific Awards:

• K99/R00 Pathway to Independence Award (2023)
• Janet D. Rowley Research Day Award (2022)
• President Scholarship, ECNU (2017)
• National Scholarship (2016)
• Multiple travel awards (2023–2024)

Labs & Collaborations: The Zhou Lab is located in the Medical Education & Research Building (Floor 11), Temple University Medical Campus. It combines molecular biology, nanoparticle engineering, and in vivo models to advance therapies for ARDS, viral pneumonia, and fibrotic disorders.